Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ART-ER Attractiveness Research Territory is the Emilia-Romagna region’s joint stock consortium company dedicated to fostering sustainable growth through the development of innovation, knowledge, internationalization, and attractiveness. It was formed by merging ASTER and ERVET. While it does not develop drugs or therapies directly, ART-ER plays a central role in coordinating regional clusters—including Clust-ER Health—and supporting research infrastructure for biotechnology, pharmaceuticals, biomedical devices, regenerative medicine, omic sciences, digital health technologies and more. It manages projects involving laboratory construction for pharmacy and biotechnology departments, organizes major bioeconomy events, supports startups, facilitates academic-industry partnerships, and helps drive the competitiveness of Emilia-Romagna’s health industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ART-ER Attractiveness Research Territory.